Valuation: Unichem Laboratories Limited

Market Cap 20.68B 217M 190M 174M 163M 308M 313M 2.1B 813M 10.14B 816M 798M 34.95B P/E 2024
-48.8x
P/E 2025 35.6x
Enterprise Value 24.38B 256M 224M 206M 192M 363M 369M 2.47B 959M 11.96B 962M 941M 41.21B EV / Sales 2024
2.07x
EV / Sales 2025 2.49x
Free-Float
28.71%
Yield 2024 *
-
Yield 2025 -
1 day-1.20%
1 week+0.98%
Current month-1.41%
1 month+22.85%
3 months+52.57%
6 months+5.48%
Current year+3.74%
1 week 427.3
Extreme 427.3
487.15
1 month 353.5
Extreme 353.5
515.55
Current year 280
Extreme 280
515.55
1 year 280
Extreme 280
656.85
3 years 280
Extreme 280
949.85
5 years 197.5
Extreme 197.5
949.85
10 years 75.1
Extreme 75.1
949.85
Manager TitleAgeSince
Chief Executive Officer 57 10/08/2023
Director of Finance/CFO - 08/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 22/08/1977
Director/Board Member 53 10/08/2023
Director/Board Member 57 10/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%+0.98%-21.68%+19.87% 343M
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
+3.15%-1.94%+26.41%+20.22% 339B
-0.29%+1.37%+42.24%+39.91% 301B
-0.04%+1.46%+32.36%+44.70% 292B
-1.45%+3.48%-24.87%-39.22% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
Average +1.26%+4.79%+25.99%+53.59% 370.01B
Weighted average by Cap. +1.40%+5.21%+41.84%+81.33%

Financials

2024 2025
Net sales 17.05B 179M 156M 144M 134M 254M 258M 1.73B 671M 8.36B 672M 658M 28.81B 21.11B 222M 194M 178M 166M 315M 320M 2.14B 830M 10.35B 833M 814M 35.68B
Net income -705M -7.4M -6.47M -5.94M -5.54M -10.5M -10.68M -71.52M -27.72M -346M -27.8M -27.19M -1.19B 1.38B 14.45M 12.62M 11.59M 10.81M 20.49M 20.84M 140M 54.08M 675M 54.24M 53.06M 2.32B
Net Debt 953M 10.01M 8.74M 8.03M 7.49M 14.19M 14.43M 96.67M 37.47M 467M 37.57M 36.76M 1.61B 3.7B 38.89M 33.98M 31.2M 29.1M 55.16M 56.09M 376M 146M 1.82B 146M 143M 6.26B
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
3,142
Date Price Change Volume
03/07/26 459.85 -0.77% 2,137
02/07/26 ₹463.40 -2.21% 3,956
01/07/26 ₹473.85 +2.03% 16,644
30/06/26 ₹464.40 +2.43% 10,673
29/06/26 ₹453.40 +4.86% 20,985
  1. Stock Market
  2. Stocks
  3. UNICHEMLAB Stock